Dividends 11 February 2026 - 14 May 2026

ANZ Group Holdings Dividend Update: $248 Million Share Purchase Sets Up July Payout
···

ANZ Group Holdings Dividend Update: $248 Million Share Purchase Sets Up July Payout

ANZ will buy about A$248 million of its own shares on market to meet its 2026 interim dividend reinvestment plan, appointing UBS Securities Australia to handle the purchase. The interim dividend remains at 83 Australian cents a share, payable July 1. DRP participation stands at 9.9% of shares, BOP at 2.4%. If the buyback is not completed, ANZ will issue new shares to meet obligations.
May 15, 2026
GSK Stock Goes Ex-Dividend Today: Why the 17p Payout Comes With a Bigger Pipeline Test
···

GSK Stock Goes Ex-Dividend Today: Why the 17p Payout Comes With a Bigger Pipeline Test

GSK shares traded ex-dividend in London on May 14, with a 17 pence first-quarter payout due July 9. The company began the final tranche of its £2 billion buyback on May 11, having repurchased £1.82 billion so far. GSK signed a deal with Chia Tai Tianqing for bepirovirsen in China, where the drug is under priority review. Bepirovirsen is not yet approved; the FDA’s target decision date is Oct. 26, 2026.
May 14, 2026
Legal & General Shares: The 8.6% Dividend Yield Is Back in Play After Ex-Dividend Week
···

Legal & General Shares: The 8.6% Dividend Yield Is Back in Play After Ex-Dividend Week

Legal & General shares traded at 252.8p/252.9p on Monday, up 0.28%, after going ex-dividend last week, locking in a 15.67p final payout for existing holders. The FTSE 100 insurer’s 2025 full-year dividend is set at 21.79p per share, with the board guiding for 2% annual growth after 2024. Legal & General also announced a £1.2 billion share buyback in March. Core operating profit rose 6% to £1.623 billion.
April 27, 2026
GSK share price set for ex-dividend week after Friday rise — what investors watch next
···

GSK share price set for ex-dividend week after Friday rise — what investors watch next

GSK shares closed Friday up 1.1% at 2,161 pence, ahead of a Feb. 19 ex-dividend date for its 18 pence Q4 payout. The company reaffirmed a £2 billion buyback through mid-2026 and expects 70 pence per share in 2026 dividends. The European Commission approved Nucala for certain COPD patients. China accepted GSK’s regulatory filing for its RSV vaccine Arexvy.
February 15, 2026
Reckitt Benckiser share price nudges higher as investors eye Feb. 20 special dividend
···

Reckitt Benckiser share price nudges higher as investors eye Feb. 20 special dividend

Reckitt shares rose 0.7% to 6,358 pence in early London trading Wednesday, outperforming a weaker STOXX 600. Investors are positioning ahead of a 235p special dividend and share consolidation set for Feb. 20, both approved by shareholders in January. The company completed a £1 billion buyback and confirmed the consolidation took effect Feb. 2. Next earnings are due March 5.
February 11, 2026